Lymphoma, Research and Clinical Trials

Meet the investigator: Stephen M. Ansell, M.D., Ph.D.

By Nicole Ferrara • June 13, 2018
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue of Forefront, Stephen M. Ansell, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, discusses his lymphoma research.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer lymphoma Lymphoma research Research and Clinical Trials
Subscribe
Request an Appointment
Find a Clinical Trial
Sorting out T-cell lymphoma

Dr. Andrew Feldman and his team are helping to redefine the classification of T-cell lymphomas, an often fatal group of immune system tumors.

Understanding, treating lymphoma

Hematologist Dr. Stephen Ansell discusses the different treatment options for lymphoma.

Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma

Researchers found that the addition of brentuximab vedotin to standard chemotherapy improves overall survival in people with Hodgkin Lymphoma.